• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子USF2和ONECUT2对β-葡萄糖脑苷脂酶的直接和间接调控

Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2.

作者信息

Ging Kathi, Frick Lukas, Schlachetzki Johannes, Armani Andrea, Zhu Yanping, Gilormini Pierre-André, Dhingra Ashutosh, Böck Desirée, Marques Ana, Deen Matthew, Chen Xi, Serdiuk Tetiana, Trevisan Chiara, Sellitto Stefano, Pisano Claudio, Glass Christopher K, Heutink Peter, Yin Jiang-An, Vocadlo David J, Aguzzi Adriano

机构信息

Institute of Neuropathology, University of Zurich, Zurich, Switzerland.

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.

出版信息

NPJ Parkinsons Dis. 2024 Oct 22;10(1):192. doi: 10.1038/s41531-024-00819-7.

DOI:10.1038/s41531-024-00819-7
PMID:39438499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11496744/
Abstract

Mutations in GBA1 encoding the lysosomal enzyme β-glucocerebrosidase (GCase) are among the most prevalent genetic susceptibility factors for Parkinson's disease (PD), with 10-30% of carriers developing the disease. To identify genetic modifiers contributing to the incomplete penetrance, we examined the effect of 1634 human transcription factors (TFs) on GCase activity in lysates of an engineered human glioblastoma line homozygous for the pathogenic GBA1 L444P variant. Using an arrayed CRISPR activation library, we uncovered 11 TFs as regulators of GCase activity. Among these, activation of MITF and TFEC increased lysosomal GCase activity in live cells, while activation of ONECUT2 and USF2 decreased it. While MITF, TFEC, and USF2 affected GBA1 transcription, ONECUT2 might control GCase trafficking. The effects of MITF, TFEC, and USF2 on lysosomal GCase activity were reproducible in iPSC-derived neurons from PD patients. Our study provides a systematic approach to identifying modulators of GCase activity and deepens our understanding of the mechanisms regulating GCase.

摘要

编码溶酶体酶β-葡萄糖脑苷脂酶(GCase)的GBA1基因突变是帕金森病(PD)最常见的遗传易感性因素之一,10%至30%的携带者会患上这种疾病。为了确定导致不完全显性的基因修饰因子,我们研究了1634种人类转录因子(TFs)对工程化人类胶质母细胞瘤细胞系裂解物中GCase活性的影响,该细胞系对致病性GBA1 L444P变体纯合。使用阵列CRISPR激活文库,我们发现了11种TFs作为GCase活性的调节因子。其中,MITF和TFEC的激活增加了活细胞中溶酶体GCase的活性,而ONECUT2和USF2的激活则降低了它。虽然MITF、TFEC和USF2影响GBA1转录,但ONECUT2可能控制GCase的运输。MITF、TFEC和USF2对溶酶体GCase活性的影响在PD患者诱导多能干细胞衍生的神经元中是可重复的。我们的研究提供了一种系统的方法来识别GCase活性的调节因子,并加深了我们对调节GCase机制的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/cb048333ee97/41531_2024_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/87f477fa03ed/41531_2024_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/d15a0cf02c6b/41531_2024_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/63e0d5ad4c0f/41531_2024_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/0ef287174401/41531_2024_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/95c9a139d3eb/41531_2024_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/8d48f5b06bb5/41531_2024_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/cb048333ee97/41531_2024_819_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/87f477fa03ed/41531_2024_819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/d15a0cf02c6b/41531_2024_819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/63e0d5ad4c0f/41531_2024_819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/0ef287174401/41531_2024_819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/95c9a139d3eb/41531_2024_819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/8d48f5b06bb5/41531_2024_819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0f6/11496744/cb048333ee97/41531_2024_819_Fig7_HTML.jpg

相似文献

1
Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2.转录因子USF2和ONECUT2对β-葡萄糖脑苷脂酶的直接和间接调控
NPJ Parkinsons Dis. 2024 Oct 22;10(1):192. doi: 10.1038/s41531-024-00819-7.
2
Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.从基于细胞的筛选中鉴定出新型的β-葡糖脑苷脂酶伴侣化合物,可减少 iPS 衍生神经元细胞中病理性积累的葡糖基神经酰胺。
SLAS Discov. 2023 Oct;28(7):344-349. doi: 10.1016/j.slasd.2023.06.002. Epub 2023 Jun 25.
3
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
4
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.一种野生型葡萄糖脑苷脂酶调节剂改善帕金森病多巴胺能神经元模型中的致病表型。
Sci Transl Med. 2019 Oct 16;11(514). doi: 10.1126/scitranslmed.aau6870.
5
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.安布罗醇诱导缺陷型葡萄糖脑苷脂酶的恢复与 GBA1 突变型帕金森病细胞中 LIMP-2 和神经鞘脂激活蛋白 C 水平的升高有关。
Neurobiol Dis. 2015 Oct;82:235-242. doi: 10.1016/j.nbd.2015.06.008. Epub 2015 Jun 19.
6
Genome-wide association study of glucocerebrosidase activity modifiers.葡萄糖脑苷脂酶活性调节剂的全基因组关联研究
Res Sq. 2024 Jun 7:rs.3.rs-4425669. doi: 10.21203/rs.3.rs-4425669/v1.
7
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.
8
Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease.利用其转运蛋白 LIMP-2 激活和纯化β-葡糖脑苷脂酶——对戈谢病和帕金森病新型治疗策略的启示。
Adv Sci (Weinh). 2024 Jul;11(25):e2401641. doi: 10.1002/advs.202401641. Epub 2024 Apr 26.
9
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.葡萄糖脑苷脂酶缺陷是帕金森病的主要危险因素。
Front Aging Neurosci. 2020 Apr 21;12:97. doi: 10.3389/fnagi.2020.00097. eCollection 2020.
10
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.靶向 GBA1 通路以减缓帕金森病:临床方面、发病机制和新治疗途径的见解。
Pharmacol Ther. 2023 Jun;246:108419. doi: 10.1016/j.pharmthera.2023.108419. Epub 2023 Apr 19.

本文引用的文献

1
The pathogenesis of Parkinson's disease.帕金森病的发病机制。
Lancet. 2024 Jan 20;403(10423):293-304. doi: 10.1016/S0140-6736(23)01478-2.
2
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology.溶酶体作为细胞分解代谢、代谢信号和器官生理学的协调者。
Nat Rev Mol Cell Biol. 2024 Mar;25(3):223-245. doi: 10.1038/s41580-023-00676-x. Epub 2023 Nov 24.
3
Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
PLEKHG4 结构域包含 Pleckstrin homology 和 RhoGEF 结构域,可导致 RhoGTPases 的激活,从而促进甲状腺癌细胞的恶性表型。
Apoptosis. 2023 Oct;28(9-10):1315-1331. doi: 10.1007/s10495-023-01861-1. Epub 2023 Jun 19.
4
Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy.神经病变型戈谢病中的神经炎症:小胶质细胞和自然杀伤细胞的作用、生物标志物,以及对底物还原治疗的反应。
Elife. 2022 Aug 16;11:e79830. doi: 10.7554/eLife.79830.
5
A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells.一种多功能荧光猝灭底物,可用于定量测量活细胞内的葡萄糖脑苷脂酶活性。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2200553119. doi: 10.1073/pnas.2200553119. Epub 2022 Jul 12.
6
Quantifying lysosomal glycosidase activity within cells using bis-acetal substrates.使用双缩醛底物定量细胞内溶酶体糖苷酶活性。
Nat Chem Biol. 2022 Mar;18(3):332-341. doi: 10.1038/s41589-021-00960-x. Epub 2022 Feb 24.
7
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity.溶酶体葡萄糖脑苷脂酶活性测定策略的评估。
Mov Disord. 2021 Dec;36(12):2719-2730. doi: 10.1002/mds.28815. Epub 2021 Oct 6.
8
Inhibition of microglial β-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons.抑制小胶质细胞的β-葡糖脑苷脂酶会阻碍小胶质细胞介导的神经元抗氧化和保护反应。
J Neuroinflammation. 2021 Sep 22;18(1):220. doi: 10.1186/s12974-021-02272-2.
9
Parkinson's Disease Genetics and Pathophysiology.帕金森病遗传学与病理生理学。
Annu Rev Neurosci. 2021 Jul 8;44:87-108. doi: 10.1146/annurev-neuro-100720-034518.
10
Advances in targeting 'undruggable' transcription factors with small molecules.小分子靶向“不可成药”转录因子的研究进展。
Nat Rev Drug Discov. 2021 Sep;20(9):669-688. doi: 10.1038/s41573-021-00199-0. Epub 2021 May 18.